Skip to main content
Amit Etkin, MD, Psychiatry, Stanford, CA

AmitEtkinMD

Psychiatry Stanford, CA

Associate Professor, Psychiatry & Behavioral Science, Stanford University Faculty, Stanford Neurosciences Institute, Stanford University Investigator, MIRECC, Palo Alto VA

Dr. Etkin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Etkin's full profile

Already have an account?

  • Office

    401 Quarry Rd
    Stanford, CA 94304
    Phone+1 650-723-6661

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 2006 - 2010
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2006

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - 2025
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans  
    Jerome A Yesavage, Michael Thase, Steven D Forman, Amit Etkin, Mark S George, JAMA

Authored Content

  • Decoding MoodOctober 2018
  • Decoding MoodOctober 2018
  • S132. Cerebral Blood Perfusion Predictors of Antidepressant Response in Major Depressive DisorderApril 2018
  • S131. Resting State Functional Connectivity Patterns Differentially Predict Treatment Outcomes to Sertraline Versus Placebo in Patients with Major Depressive DisorderApril 2018
  • Join now to see all

Press Mentions

  • Spravato Is Just the Beginning in a New Wave of Depression Meds
    Spravato Is Just the Beginning in a New Wave of Depression MedsNovember 11th, 2024
  • Precision Psychiatry and the Mental Health Treatment Revolution
    Precision Psychiatry and the Mental Health Treatment RevolutionOctober 8th, 2024
  • Study Shows the Power of Electroencephalography and Machine Learning to Help Predict Response (Or Lack of It) to Psychotherapy in Patients with PTSD
    Study Shows the Power of Electroencephalography and Machine Learning to Help Predict Response (Or Lack of It) to Psychotherapy in Patients with PTSDMay 2nd, 2023
  • Join now to see all